EFG
BIIB icon

Everhart Financial Group’s Biogen BIIB Stock Holding History

Everhart Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$398K Buy
1,840
+2
+0.1% +$383 0.03% 308
2026
Q1 		$337K Buy
1,838
+181
+11% +$33.4K 0.03% 338
2025
Q4 		$292K Buy
+1,657
New +$271K 0.03% 330

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
NGM
North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

Everhart Financial Group's BIIB Position: Q2 2026 in Review

Everhart Financial Group increased its Biogen (BIIB) stake by 0.11% in Q2 2026, buying an estimated $383 and bringing the position to 1,840 shares worth $398K. The position accounts for 0.03% of the portfolio, ranked #308.

Everhart Financial Group first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 205 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Everhart Financial Group held 1,840 shares of Biogen worth $398K as of Q2 2026.
  • Everhart Financial Group bought 2 Biogen shares in Q2 2026, an estimated $383.
  • Biogen made up 0.03% of Everhart Financial Group's portfolio in Q2 2026, its #308 holding.
  • Everhart Financial Group first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 205 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.